Navigation Links
Immtech Reports Fiscal Second Quarter 2008 Results
Date:11/8/2007

NEW YORK, Nov. 8 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM) today announced results for its fiscal second quarter ended September 30, 2007.

For the three months ended September 30, 2007, revenues were $1,030,000, as compared to $491,000 for the three months ended September 30, 2006. The increase was primarily attributable to revenues relating to a licensing agreement and research agreement. Loss from operations for the three months ended September 30, 2007 was $3,466,000, as compared to a loss from operations of $1,753,000 for the three months ended June 30, 2006. The three month period ended September 30, 2006 included a receivable of $1,874,000 relating to the Neurochem litigation award. Net loss attributable to common stockholders for the three months ended September 30, 2007 was $3,469,000, or $0.23 per share, compared to a loss of $1,758,000, or $0.13 per share, in the previous year.

At September 30, 2007, unrestricted cash and cash equivalents were $9,840,000 as compared to $12,462,000 at March 31, 2007. For the same periods, restricted funds on deposit were $694,000 and $3,119,000, respectively. Subsequent to September 30, 2007, a payment of $5,123,000 was received to further the development of pafuramidine, the Company's oral drug candidate, in the Phase III African sleeping sickness trial.

During the three-month period ended September 30, 2007, several significant milestones were achieved. In addition to the Par Pharmaceutical agreement, Immtech received orphan drug status from the USFDA for pafuramidine to treat malaria and African sleeping sickness, added a new board member and a strategic advisor to the team, and received from China's State Food and Drug Administra
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Chinese SFDA Grants Immtech Fast Track Status
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
6. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  Paper Pak ... has developed APLS ® Body Guard Bio, ... the spread of bacteria and virus while protecting ... Body Guard Bio features a rugged, external nylon ... that create a leak-proof inner chamber that contains ...
(Date:10/22/2014)... 2014 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral ... results from its Phase IIa clinical trial of ... treat type 1 diabetes. The trial was conducted in ... a U.S. Food and Drug Administration (FDA) Investigational ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
... UBM Electronics leading brands, EE Times ... and Events Division of UBM Canon as a partner ... comprehensive program for designers, developers, and engineering managers involved ... conference and exposition is being held February 8-10, 2011, ...
... RetireSafe, a 400,000-supporter strong national advocacy group for ... & Coverage Advisory Committee (MEDCAC) to support the ... new Provenge treatment procedure for prostate cancer patients. ... "consider not only the many Americans suffering from ...
Cached Medicine Technology:UBM Electronics' EE Times and EDN Partner with Medical Electronics Design, MD+DI, and Others on DesignMED Event for Designers of Medical Electronics Devices 2UBM Electronics' EE Times and EDN Partner with Medical Electronics Design, MD+DI, and Others on DesignMED Event for Designers of Medical Electronics Devices 3RetireSafe Urges Support for Provenge Prostate Cancer Treatment 2
(Date:10/25/2014)... Limbkeepers® announced today that they will be ... Begley Jr, airing 1st QTR 2015 via Discovery Channel. ... Innovations will focus on Limbkeepers® non compression knit sleeves, ... on arms, hands, and legs from abrasion, skin tears ... which help reduce injuries, allow for continued daily activities, ...
(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... that causes common cold sores -- herpes simplex -- might ... researchers suggest. In fact, being a carrier of certain ... disease, the researchers found. "The identification of a ... is a breakthrough," said lead researcher Dr. Hugo Lovheim, an ...
(Date:10/25/2014)... News) -- Researchers who discovered antibiotics in farmed ... for concern. The use of antibiotics in ... consumption contribute to the development of antibiotic-resistant bacteria ... from the study. Each year in the ... people and kill about 23,000, according to the ...
(Date:10/25/2014)... (HealthDay News) -- Current osteoporosis screening guidelines and ... at risk for osteoporosis-related fractures, a new study ... we need tools that help us accurately predict ... we can target these at-risk people for preventive ... medicine in the division of general internal medicine ...
(Date:10/25/2014)... shorter, darker days can trigger a type of depression, ... People affected by seasonal affective disorder, also ... even have trouble getting out of bed. In extreme ... Halaris, a professor in the department of psychiatry and ... Medicine. "Seasonal affective disorder should not be taken ...
Breaking Medicine News(10 mins):Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:Dark Days Here for Folks With Seasonal Depression 2
... American Dental Association Kicks Off National Children,s Dental Health,Month ... Feb. 4 February is National,Children,s Dental Health Month. ... to raise awareness among families and policymakers,about the critical ... for the sixth year in a row, the ADA ...
... cable channels, crocodiles are among natures most fearsome predators. When ... 23% of their own body weight. This is analogous to ... weighing 30 pounds. But what to do with all of ... crocodilians risk death from within, or if they are young, ...
... and CEO Also Points Out Fundamental Flaw That May ... Undermine Proposed Plans to Achieve this Objective, ... Bulletin Board: MDFI), a company specializing in,portable electronic medical ... their nearly unanimous support for,the adoption of electronic medical ...
... a previously unsuspected protein as a key player in ... The study, published by Cell Press in the February ... the molecular response to breast cancer therapies that target ... and are dependent on estrogen signaling. Drugs that target ...
... Precision, STEINBACH, Manitoba, Feb. 4 Featuring ... Perkins & Will, Mid Canada Millwork has,completed millwork ... UCLA Medical Center, located on the UCLA campus ... of wall paneling and custom,millwork in every room, ...
... Calif., Feb. 4 Renowned esthetician, Karen,Dunlap, has ... food recognized as the number-one most nutritious and ... Connecting the dots between science and,nature, Dunlap discovered ... ingestion -- magnifies its benefits. Her new signature ...
Cached Medicine News:Health News:A Reminder to Parents: Early Dental Visits Essential to Children's Health 2Health News:A Reminder to Parents: Early Dental Visits Essential to Children's Health 3Health News:Gotta have heart! 2Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 2Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 3Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 4Health News:MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records 5Health News:Unsuspected protein determines resistance to breast cancer treatment 2Health News:Breakthrough 'Acai Berry Anti-Aging Facial' Applies Benefits of Nature's Super-Food to the Skin 2
The GelPort XE hand access system combines the technology of the GelSeal® cap with the retraction and protection of the Alexis wound retractor....
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
... SleepStyle 200 series offers a range ... models. The design delivers therapy to ... features promote results in commercial and ... strongest differentiator in the SleepStyle 200 ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
Medicine Products: